Danish-born Suzy Wengel, a dietitian and CEO of a Biotech company, is the author behind 'The Scandi Sense Diet.' Her eating plan is based on the simple principle of measuring your portions of food for each meal with handfuls. Each meal should consist of four handfuls — one each of protein and…
News
- This Scandinavian diet created by a Danish CEO and dietitian has been hailed 'the simplest in the ...
- Asana BioSciences Announces Presentations of ASN003 (BRAF/PI3K inhibitor) and ASN007 ...
LAWRENCEVILLE, N.J.--(BUSINESS WIRE)--Asana BioSciences, LLC, an oncology focused, clinical stage biopharmaceutical company, today announced that it will present updates for two of its lead molecules in clinical development at the American Association for Cancer Research (AACR) Annual ...…
- CytoBioscience CEO: Going public will speed growth
CytoBioscience expects to become a much stronger company with significantly more access to capital once its transformation from being privately owned to publicly traded is complete. I reported last month that the San Antonio-based biotech had essentially acquired, through merger, a subsidiary of…
- A small boutique landed a lucrative lead role on the $8.7 billion Novartis-AveXis deal
Dyal Co., a small M&A boutique, landed a lead role on the the $8.7 billion Novartis-AveXis deal. The firm has roughly 15 employees and is led by ex-Goldman Sachs rainmaker Gordon Dyal. Dyal was the former co-chairman of investment banking at Goldman, where he spent years leading M&A…
- Novartis just handed out a $8.7 billion endorsement for new therapies that are changing how we ...
Novartis isn't the only big pharma/biotech to be interested in gene and cell therapies. In January, Celgene made a $9 billion bet on Juno Therapeutics, a cancer drugmaker that's working on cell therapies. The deal also drummed up excitement for a possible deal for Bluebird Bio, another company…